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Abstract
Background: Owing to their low prevalence, single rare conditions are difficult to monitor through current state passive and
active case ascertainment systems. However, such monitoring is important because, as a group, rare conditions have great impact
on the health of affected individuals and the well-being of their caregivers. A viable approach could be to conduct passive and
active case ascertainment of several rare conditions simultaneously. This is a report about the feasibility of such an approach.
Objective: To test the feasibility of a case ascertainment system with passive and active components aimed at monitoring 3 rare
conditions simultaneously in 3 states of the United States (Colorado, Kansas, and South Carolina). The 3 conditions are spina
bifida, muscular dystrophy, and fragile X syndrome.
Methods: Teams from each state evaluated the possibility of using current or modified versions of their local passive and active
case ascertainment systems and datasets to monitor the 3 conditions. Together, these teams established the case definitions and
selected the variables and the abstraction tools for the active case ascertainment approach. After testing the ability of their local
passive and active case ascertainment system to capture all 3 conditions, the next steps were to report the number of cases detected
actively and passively for each condition, to list the local barriers against the combined passive and active case ascertainment
system, and to describe the experiences in trying to overcome these barriers.
Results: During the test period, the team from South Carolina was able to collect data on all 3 conditions simultaneously for
all ages. The Colorado team was also able to collect data on all 3 conditions but, because of age restrictions in its passive and
active case ascertainment system, it was able to report few cases of fragile X syndrome. The team from Kansas was able to collect
data only on spina bifida. For all states, the implementation of an active component of the ascertainment system was problematic.
The passive component appears viable with minor modifications.
Conclusions: Despite evident barriers, the joint passive and active case ascertainment of rare disorders using modified existing
surveillance systems and datasets seems feasible, especially for systems that rely on passive case ascertainment.
(JMIR Public Health Surveill 2016;2(2):e151)   doi:10.2196/publichealth.5516
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Introduction
Methods for Surveillance of Rare Conditions
Surveillance is used to gather data and knowledge that can be
used to identify and control a health problem or to improve a
public health program or service [1]. Birth defects monitoring
programs, which focus primarily on identifying diagnosed cases,
have widely used passive systems that gather data from
administrative data such as hospital discharge records and
administrative records from public insurers [2]. However, these
systems can both over- and underestimate the actual prevalence
of conditions, because coding for billing purposes is not always
accurate or complete [3-5].
Active case ascertainment methods are considered the “gold
standard” in public health surveillance [6]. These methods
involve trained coders collecting data directly from medical
providers, health service providers, and educational institutions
to identify cases. The biggest challenge for using these methods
is locating people with any of the conditions of interest within
a designated geographic area [7]. Thus, population-based
approaches must actively review records from diverse sources
(eg, inpatient and outpatient settings, rehabilitation services,
disability-specific programs, schools) [8].
Rare conditions such as spina bifida, fragile X syndrome, and
muscular dystrophy can be especially difficult to monitor.
Among these 3 conditions, only spina bifida is recognizable at
birth and more easily included in state-based birth defects
monitoring systems. The other 2 conditions—fragile X syndrome
and muscular dystrophy—are not apparent in the early days of
life and no laboratory test or biomarker is commonly used to
screen newborns for these conditions. Instead, fragile X
syndrome and muscular dystrophy are often identified during
early childhood after parents and primary care providers note
developmental or motor deficits. Both conditions require specific
genetic tests to confirm their diagnosis; however, this usually
occurs in an outpatient setting and does not require
hospitalization. Thus, the data sources for passive surveillance
of these conditions need to be extended not only to genetic
laboratories but also to specialty care clinics where diagnosis
is confirmed typically after multiple visits [9-11].
Spina Bifida
Spina bifida occurs when the neural tube fails to close properly
during fetal development [12-14]. The incidence of spina bifida
detected at birth (namely, meningocele and myelomeningocele)
decreased from approximately 2.5/10,000 (95% CI 2.3-2.7) in
1992 to 2.0/10,000 (95% CI 1.9-2.1) in 2001. The National
Birth Defects Prevention Network estimated the prevalence of
spina bifida (without hydrocephaly) was 3.5/10,000 live births
(95% CI 3.31-3.68) [14].
Muscular Dystrophy
Muscular dystrophies are a group of genetic diseases
characterized by progressive skeletal muscle degeneration and
weakness [15]. Although more than 30 forms of muscular
dystrophy have been identified, there are 9 major forms [16].
The most common muscular dystrophies, Duchenne muscular
dystrophy and Becker muscular dystrophy, together have an
estimated prevalence of 1.38/10,000 males aged 5 to 24 years
[16]. Other major forms (eg, distal, Emery-Dreifuss) each have
a prevalence of 1 to 2 per 100,000 [17,18].
Fragile X Syndrome
Fragile X syndrome results from a mutation in the fragile X
mental retardation 1 gene, FMR1, on the X chromosome [19].
Impairment severity can range from relatively mild learning
disabilities to moderate intellectual disability and autism or
“autistic-like” behaviors. Approximately 1 in 3600 to 4000
males and 1 in 4000 to 6000 females is born with the full
mutation for fragile X. The vast majority of males and about
50% of females with the full mutation will have fragile X
syndrome [19-21].
Importance of Surveillance of These 3 Rare Conditions
These conditions have low prevalence but a great impact on
long-term disability, mortality, cost, and caregiver stress
[12,22,23]. Obtaining a better estimate of state prevalence is a
necessary starting point for assessing the impact. Such tracking
requires the following: a flexible population scope (eg, specific
to infants and young children); expansion of data sources (eg,
health care specialists and tertiary medical centers); and
labor-intensiveness (eg, data abstracted from a large number of
health care practices).
Spina bifida, muscular dystrophy, and fragile X syndrome were
chosen for this feasibility study because (1) they are all low
incidence conditions with high health and economic impact; (2)
they encompass a wide range of etiological, physical, and
cognitive symptoms; (3) they represent various degrees of
difficulty for passive and active case ascertainment; (4) public
and private organizations have long-standing active research
programs and data collections on these 3 conditions; and (5)
the US Congress has provided special funding to monitor and
study these 3 conditions [24-27].
The low prevalence of rare disorders makes impractical the
development of a separate passive and active case ascertainment
system for each condition but lends itself to a combined case
ascertainment system that would monitor several conditions at
once. Such an integrated passive and active case ascertainment
system could serve as a model for other low prevalence and
high-impact conditions. Simultaneous passive and active case
ascertainment of rare conditions may lead to public health
interventions that improve the health of a sizable segment of
the population affected by these conditions. Thus, the purpose
of this paper is to report on the feasibility of developing a rare
conditions passive and active case ascertainment system that
simultaneously monitors spina bifida, muscular dystrophy, and
fragile X syndrome within a state. In each of the 3 states in
which this work was undertaken, objectives were to (1) assess
the ability of the local passive and active case ascertainment
systems to capture the 3 rare disorders, (2) capture preliminary
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state prevalence estimates of the conditions, and (3) discover
barriers and facilitators to such implementation. Findings can
provide lessons for future rare conditions passive and active
case ascertainment activities in states with similar systems to
these.
Methods
Justification of States Included in the Study
The design of this feasibility study required that the states
included were at varying levels of readiness toward
implementing a rare conditions passive and active case
ascertainment program. The state teams were selected by the
study team, based on knowledge of states with disability
epidemiologists and their understanding of data capability. States
were also selected so that they roughly conformed to one each
on the high, medium, and lower levels of passive and active
case ascertainment sophistication. Colorado (high) and South
Carolina (medium) were selected because of their established
and state-supported birth defects passive and active case
ascertainment system and, in the case of South Carolina, other
integrated data system capacities. Kansas (low) was selected
because it was home to a disability epidemiologist who had
published articles using the Medicaid system to analyze
disability and health issues. The approach in each state was to
identify existing passive and active case ascertainment systems
and data sources that could be expanded to implement a more
comprehensive system within 2 years. The 2-year duration was
chosen to allow up to 1 year for the assessment of current
passive and active case ascertainment systems, standardization
of case definitions, and selection of variables for the active case
ascertainment component; and an additional year to test the
feasibility of modestly enhancing the existing systems to assess
what is feasible and to compare the three systems. Within each
state, systems were compared by (1) using data from the active
system to assess the accuracy of cases identified in the passive
system and (2) capture-recapture methodology to get estimates
of the prevalence of the 3 conditions.
The first step was to document how states varied in their
different resources, approaches, and levels of experience in
conducting passive and active case ascertainment. Table 1
compares passive and active case ascertainment programs in
the 3 states [28,29]. The same sources and variables were
searched and assessed for all 3 conditions.
Colorado has a mature, state-mandated, birth defects surveillance
system in the health department, which requires reporting up
to age 3 years. This system conducts active case finding through
administrative data sources and it includes reports of spina bifida
that mirror expected prevalence. Colorado also has a Centers
for Disease Control and Prevention (CDC)–funded muscular
dystrophy surveillance program (Muscular Dystrophy
Surveillance, Tracking, and Research Network; MD STARnet)
that uses active surveillance in neuromuscular clinics to identify
childhood-onset cases. The MD STARnet system had been
ongoing for 10 years at the beginning of our project. The
challenge for Colorado was to identify cases of fragile X
syndrome, because there had only been a few cases reported in
the past decade. Fragile X syndrome is an inherited cause of
intellectual disability, which is not apparent at birth. When
intellectual disability is diagnosed in a child, a genetic diagnostic
examination is needed to make the fragile x syndrome diagnosis;
thus, in many cases this is not done before the child’s third
birthday. The fact that Colorado only had a few cases of fragile
X syndrome reported before the onset of the project suggests
that even established birth defects systems need expanded
authority through their legislature to collect information about
people who are older than 3 years. The Colorado passive and
active case ascertainment system needs to pursue sources of
reporting, such as the fragile X clinic in their state, if they want
to conduct passive and active case ascertainment of rare
conditions. South Carolina has a birth defects case ascertainment
system that relies on active hospital record abstraction for spina
bifida and other early identifiable birth defects. This system had
been collecting cases of spina bifida at the prevalence rate that
was expected. South Carolina also has a well-established
administrative data system that allows linkage among a large
number of public insurance, vital records, and state service
agency secondary data sources. This system was available for
passive ascertainment. The South Carolina project developed
an active surveillance system in 5 counties to compare the active
and passive ascertainment of the 3 conditions. Kansas, likewise,
has a birth defects surveillance system housed in the health
department that primarily relied on birth certificate reporting
of birth defects. This system has a passive case ascertainment
component and no active case ascertainment component. Thus,
the challenge for Kansas was to develop a small, active, case
ascertainment component for this project.
During the first year of this 2-year project the teams from
Colorado and South Carolina began with the identification of
existing data sources. The Kansas team spent the first year
cataloging features they could use from the other 2 states that
had well-developed passive and active case ascertainment
systems, investigating the capacity of local chapters of parent
advocacy organizations for each condition, and conducting an
extensive literature review. The Kansas team worked with the
South Carolina and Colorado health departments to obtain
information about policies and procedures related to existing
passive and active case ascertainment systems, particularly on
birth defects monitoring programs.
Together, the teams from the 3 states established uniform case
definitions (including International Classification of Diseases,
Ninth Revision, or ICD-9 codes and other required elements),
variable definitions, and data abstraction tools for the active
case ascertainment approach. The codes used in the 3 states are
listed in Table 2. South Carolina and Kansas completed
institutional review board (IRB) reviews that were needed
because an active case ascertainment system that covered all
ages was being used for this project, and this expanded an
existing state statutory system.
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Table 1. Major characteristics of the case ascertainment system in 3 US states.
KansasSouth CarolinaColoradoCharacteristics
State characteristics




CRSa 25-1.5-101 to 25-1.5-105;
enacted in 1985
Legislative authority
Department of Health: Vital
Statistics, Maternal and Child
Health
Department of Health: Maternal
and Child Health
Department of Health: Epidemiol-
ogy and Environment
Location
Passive onlyPassive and activeMostly passiveCharacterization of the passive and
active case ascertainment system
Data characteristics
Case ascertainment (passive); vital
records (birth and fetal death cer-
tificates); state-based registries;
physician reports.
Case ascertainment (active); vital
records (birth, death, fetal death,
and elective termination certifi-
cates); state-based registries; deliv-
ery hospitals; pediatric and tertiary
hospitals; prenatal diagnosis facil-
ities; genetic laboratories; genetic
counseling services; genetic clin-
ics; physician reports; passive
sources; Medicaid; hospital dis-
charges; state health plan claims;
Department of Disabilities and
Special Needs.
Case ascertainment (active, pas-
sive); vital records (birth, death,
and fetal death certificates); state-
based registries; delivery hospitals;
pediatric and tertiary care hospi-
tals; genetic laboratories; genetic



















Time frame—years covered for
active case ascertainment
No limitNo limit0-3 (SB, FXS); 0-28 (MD)Age range covered, years
Medical records (1 county).Medical records (5 counties).Reascertainment and medical
records.
Data sources for the active case
ascertainment component in this
project
NoNoYesClinical review for the passive
component of this project
YesYesYesClinical review for the active
component of this project
Limited availability and intercon-
nection of data sources.
The active component could be
labor intensive.
Not enough time to change the age
of reporting FXS from 3 to 10
years.
Barriers to implementation
aCRS: Colorado Revised Statutes.
bKSA: Kansas Statutes Annotated.
cSB: spina bifida.
dMD: muscular dystrophy.
eFXS: fragile X syndrome.
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Table 2. Diagnosis codes and variables used to passively identify cases in a pilot project for a 3-state (Colorado, Kansas, South Carolina) public health
passive and active case ascertainment system for 3 rare conditions (spina bifida, muscular dystrophy, and fragile X syndrome).






G71.0 and G71.1N/A359.0, 359.1, and 359.21Muscular dystrophy
Q05 including Q05.0 to Q05.9Myelomeningocele or
meningocele variable
741.0 through 741.9Spina bifida
(without anencephalies)
aICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical Modification.
bICD-10: International Classification of Diseases, Tenth Revision.
cN/A: not applicable.
The teams assessed the status of statewide data sources for rare
conditions passive and active case ascertainment in their
respective states. All 3 states have birth defects registries that
obtain data from birth certificates. Colorado and South Carolina
queried electronic administrative data sources, including hospital
and emergency department encounters, physician office visits,
all of which include codes for conditions, services, and charges,
as well as death records.
During the second year the states carried out both active and
passive case ascertainment, documented barriers and challenges
as they arose, and made tentative estimations of the prevalence
of spina bifida, muscular dystrophy, and fragile X syndrome in
each state.
Methods by State
Each state’s methodology was based on its readiness for
combined passive and active case ascertainment, the
organization that led the project, the type of available data, and
the answers to unanticipated barriers to the implementation of
the passive and active case ascertainment system. The Guidelines
for Conducting Birth Defects Surveillance [24] was the
document that set the standards for operations in both Colorado
and South Carolina and it was used to establish activities during
this feasibility project.
Colorado
The Colorado Department of Public Health and Environment
has a sophisticated, mainly passive, birth defects case
ascertainment system that interfaces with some administrative
data sources. The state has more than 20 years of surveillance
data collection, under statutory authority, on a large array of
childhood conditions, which include active case ascertainment
data for muscular dystrophy and spina bifida.
Colorado’s Approach to Passive Case Ascertainment for
Persons With Fragile X Syndrome, Spina Bifida, and
Muscular Dystrophy
Colorado Responds to Children with Special Needs (CRCSN)
is the program in charge of birth defects monitoring and
prevention in the state. This program used case reports from
multiple external sources to ascertain cases of each of the 3
conditions of interest among children from birth to age 3 years,
for all cases meeting criteria. Case reports were entered into a
transitional computer program that prepared the case for further
processing before being posted to a core database. All case
reports went through an extensive search and/or match process
that linked cases to a unique identifier.
Colorado has participated in a number of CDC-funded
surveillance efforts that have enhanced its data collection
processes. For example, CRCSN collected data on children with
spina bifida up to age 3 years through the CDC-funded Rapid
Ascertainment project that uses a passive registry followed by
a reascertainment and medical record review as confirmation
for all live births [30]. Colorado has also participated in the
CDC-funded MD STARnet program since it began surveillance
for Duchenne and Becker muscular dystrophies in 2002 [31].
Recently, MD STARnet was expanded to include 7 additional
types of muscular dystrophy. CRCSN has collected information
on fragile X syndrome since 1994, through its passive Birth
Defects Monitoring system, but only a few cases were reported
in recent years. As part of this feasibility passive and active case
ascertainment effort the Colorado project staff met with the
director of the fragile X clinic at Children’s Hospital Colorado
in an effort to expand the passive ascertainment and explore the
possibility of conducting a medical record review to identify
persons for whom a genetics laboratory confirmation was
available. This contact was necessary to inform the director of
the clinic’s responsibility to report children younger than 3 years
with fragile X syndrome to the CRCSN system.
Colorado’s Approach to Active Case Ascertainment of
Persons With Fragile X Syndrome, Spina Bifida, and
Muscular Dystrophy
The CRCSN staff established specific guidelines for each case
definition, which required the number of times a diagnosis is
reported, the number of reporting sources, and the use of
International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) diagnosis and procedure codes. The
CRCSN did not implement an active case ascertainment system
per se; instead, it supplemented the passive system with rigorous
reascertainments and medical record reviews by physicians of
all spina bifida cases and some muscular dystrophy cases. Before
this feasibility project, this approach was not used for cases of
fragile X syndrome.
CRCSN has developed a multistep approach to monitor data
sources, specific diagnoses, over- and under-ascertainment, and
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problematic code assignment issues. Its data quality validation
procedure includes computerized and manual approaches
(computer screen review of case records, medical records review
of selected cases, and clinical consultation when difficulties
were identified). Additionally, two levels of clinical reviews
are used for diagnosis: (1) staff level (to identify problems in
report date, source of diagnosis, site of the encounter, and
ICD-9-CM codes); (2) medical specialist level (to review the
medical records and other relevant information to verify the
diagnosis).
South Carolina
In this state, faculty from the University of South Carolina
School of Public Health and the Medical University of South
Carolina partnered with the South Carolina Department of
Health and Environmental Control (DHEC) to complete this
project. The active case ascertainment was conducted by the
DHEC and the data utilized for the passive case ascertainment
system was housed within the Revenue and Fiscal Affairs (RFA)
agency. The RFA has agreements with state agencies and
organizations to store data, although each data source retains
control of the data at all times. Thus, RFA facilitated the
development of written agreements with each agency and
organization that potentially had data elements that could be
used for this project. For deidentified data projects, including
this rare conditions passive and active case ascertainment effort,
the RFA uses an algorithm that relies on source-specific personal
identifiers to create a global unique identifier. The data are
edited and standardized before being run through the search
algorithm. The global unique identifier is not associated with
any personal identifier and is used on all subsequent episodes
of services, regardless of data source or service provider. Using
the unique global identifier enables staff to use data across
multiple providers while protecting confidentiality. The
investigators of the rare conditions passive and active case
ascertainment system included one RFA staff member, a health
department investigator, and university investigators.
South Carolina’s Approach to Passive Case Ascertainment
of Persons With Fragile X Syndrome, Spina Bifida, and
Muscular Dystrophy
All persons with an ICD-9-CM primary or secondary diagnosis
code for fragile X syndrome, spina bifida, or muscular dystrophy
were identified from Medicaid, the Hospital Discharge Dataset,
and the claims from the State Health Plan that insures all
government workers and their families (Table 2). The South
Carolina DHEC Birth Defects Monitoring Program was used
to identify cases of spina bifida. For all 3 conditions, death
certificate records were used to identify unique cases from
previous periods. These cases occur if people received care out
of state or if they did not have their condition diagnosis included
when they were seen in the medical care system. These cases
were identified by International Classification of Diseases, Tenth
Revision, (ICD-10) cause-of-death codes for fragile X syndrome,
spina bifida, and muscular dystrophy from the South Carolina
DHEC. For fragile X syndrome and muscular dystrophy, South
Carolina also identified cases through the Department of
Disabilities and Special Needs, the agency that provides support
and services to people with disability.
South Carolina’s Approach to Active Case Ascertainment
of Persons With Fragile X Syndrome, Spina Bifida, and
Muscular Dystrophy
South Carolina DHEC established an active case ascertainment
component for citizens of all ages with rare conditions in 5
South Carolina counties for this project, after IRB approval.
After cases were reported to the South Carolina DHEC Birth
Defects Monitoring Program by the physician practices, a
registered nurse abstractor traveled to each practice to abstract
relevant data (ie, basic diagnosis and demographic information;
sufficient but less rigorous than the Colorado MD STARnet
protocol for muscular dystrophy) from medical records of those
who had received treatment in a clinic, hospital, or practice
located in those 5 counties. The data were then entered into an
Epi Info [32] data system for compilation, output into an SAS
[33] file for editing, linking with passive data, and analysis.
South Carolina’s Approach to Merging the Passive and
Active Systems
At the conclusion of active data collection for the 5 designated
counties, the data from the passive case ascertainment system
and the active case ascertainment system were linked and
analyzed at RFA. The data collected through the passive system
were compared with the data from the active case ascertainment
system to test the accuracy and completeness of the passive
system. Non-RFA investigators were provided with aggregate
reports.
Kansas
Congenital anomalies have been recorded in Kansas birth
certificates since 1979 and since 1982, Kansas has had, under
administrative regulations, a limited set of passive case
ascertainment activities for these anomalies [28]. In 2004, the
Kansas legislature issued the statutes for the creation of the
Birth Defects Information System (BDIS) with the aim of
collecting information on congenital anomalies and other birth
abnormalities among children younger than 5 years [28].
Currently, the BDIS includes an interface between a birth defects
database and a Web-based application from the program
Children and Youth with Special Health Care Needs, along with
relevant variables from the Vital Statistics Integrated Information
System. Thirteen anomalies are currently listed in the birth
certificates and reported to the BDIS [28].
Kansas’ Approach to Passive Case Ascertainment for
Persons With Fragile X Syndrome, Spina Bifida, and
Muscular Dystrophy
Given the strong reliance of the BDIS on birth certificates and
because spina bifida is the only one of the 3 conditions included
in this report that is diagnosed at birth, the Kansas team
developed a passive case ascertainment plan just for spina bifida.
First, the team identified cases of spina bifida using ICD-9-CM
codes (see Table 2) in a Medicaid claims database. Then,
relevant individual information from these cases was merged
with individual information from the BDIS. Finally, the
individual data were deduplicated and aggregated to obtain the
count of spina bifida cases in the state.
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Kansas’ Approach to Active Case Ascertainment for Persons
With Fragile X Syndrome, Spina Bifida, and Muscular
Dystrophy
For the active case ascertainment component, the Kansas team
mailed a letter to pediatricians, neurologists, and spina bifida
clinics in one county (Sedgwick) in Kansas asking them to report
all of their cases of spina bifida, under authority of the Kansas
Birth Defects Act (KSA 65-1241 through 65-1246). Sedgwick
County, including the city of Wichita, is a large county,
including 17.5% of the state’s total population [34]. For
professional medical record abstraction, eligible medical records
were sent to the Kansas Foundation for Medical Care (KFMC),
a state not-for-profit organization that has served as the state’s
External Quality Review Organization and information
technology resource in the state. Additionally, KFMC provided
advice on data aggregation.
Kansas’ Approach to Merging the Passive and the Active
Case Ascertainment Systems
When the active component of the project was completed,
KFMC shared the active case ascertainment dataset with the
Kansas team. These data were merged with the passive dataset
to identify the cases that were common between both datasets.
Results
Findings by State
Within the 2-year period allocated to this project, the South
Carolina team was able to use the passive and active case
ascertainment capabilities of the state to assemble a passive and
active case ascertainment system, with both passive and active
components, to simultaneously detect spina bifida, muscular
dystrophy, and fragile X syndrome. The active component of
the South Carolina team, however, was limited to 5 counties.
The Colorado team supplemented their extensive passive system
with reascertainment and clinical review of the cases; however,
because of age restrictions in reporting, this team was able to
detect only a handful of cases of fragile X syndrome. The Kansas
team was able to assemble a case ascertainment system with
passive and active components, but only for 1 condition, spina
bifida, and the active component of this system was limited to
1 county.
On the basis of cases found, the teams calculated number and
prevalence for their respective states. These estimates are
tentative, not comparable in any way from one state to the other,
and certainly not comparable to published estimates calculated
with more rigorous methods. Table 3 presents the data collected
in the 3 states, collected for spina bifida, muscular dystrophy,
and fragile X syndrome. The racial composition of cases in the
3 states differed substantially, but this composition follows the
underlying population of each state. In 2014, a total of 66% of
the South Carolina population was white, 27% black, and 5%
Hispanic, and the cases of spina bifida and muscular dystrophy
reflect this pattern. The cases of fragile X syndrome are 47%
white for active and 54% for passive. In Colorado and Kansas,
there were high proportions of missing data or “other” racial
groups noted. The male to female ratio for spina bifida was not
consistent across the 3 areas. More females than males were
identified in South Carolina and more males than females were
identified in both Colorado and Kansas. The higher proportion
of male cases identified with muscular dystrophy and fragile X
syndrome in Colorado and South Carolina (muscular dystrophy
only) reflects the fact that these 2 conditions have genetic
X-linked inheritance.
Table 4 presents the rates of spina bifida, muscular dystrophy,
and fragile X syndrome identified in this pilot project. In
Colorado, the rate for spina bifida was 3.35/10,000 for those
younger than 3 years, for muscular dystrophy the rate was
1.29/10,000, and with only 6 identified cases of fragile X
syndrome the rate was close to zero. The passive and active
case ascertainment efforts in South Carolina were for all ages,
so the denominator for South Carolina was the state population
for passive case ascertainment and the all age population of 5
counties around the metropolitan areas of Columbia and
Charleston for active case ascertainment. The South Carolina
passive rates were substantially higher than active rates for spina
bifida (2.16/10,000 for active and 12.15/10,000 for passive) and
muscular dystrophy (3.28/10,000 for active and 6.84/10,000 for
passive). For fragile X syndrome these rates were more similar,
1.20/10,000 for active and 1.65/10,000 for passive case
ascertainment. In Kansas, for the one county used for active
case ascertainment of spina bifida the rate was 0.86/10,000 and
the passive rate was 3.04/10,000.
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Table 3. Summary of data collected in a pilot project for a 3-state (Colorado, Kansas, South Carolina) public health passive and active case ascertainment





















25 (2.8)...1590 (27.1)73 (28.8)...Non-Hispanic black
296 (33.6)21 (...)3628 (61.8)138 (54.5)30 (...)Non-Hispanic white
561 (63.6)19 (...)654 (11.1)42 (16.6)28 (...)Hispanic and others
392 (55.6)26 (59.1)2266 (38.6)112 (44.3)36 (61.0)Male
490 (44.4)18 (40.9)3606 (61.4)141 (55.7)10 (16.9)Female
13 (22.0)Missing
Range 2004-2013Range 1971-201395% CI 1958-199895% CI 1982-2014Range 2010-2012Birth year, range and 95% CI
3305384689Muscular dystrophyc, N
805 (24.4)75 (19.5)16 (2.3)Non-Hispanic black
1998 (60.5)262 (68.2)379 (55.0)Non-Hispanic white
502 (15.2)47 (12.2)294 (42.7)Hispanic and others
1707 (51.6)258 (67.2)444 (64.4)Male
1598 (48.4)126 (32.8)245 (35.6)Female
1969 (24)1973 (23)1992-2011Birth year, range and mean
(SD)
7951416Fragile X syndrome, N
286 (36.0)57 (40.4)Non-Hispanic black
433 (54.5)66 (46.8)Non-Hispanic white
76 (9.6)18 (12.7)Hispanic and others
516 (64.9)88 (62.4)Male
279 (35.1)53 (37.6)Female
1981 (19)1983 (19)2007-2012Birth year, range and mean
(SD)
aColorado did not implement an active case ascertainment system per se; instead, it supplemented the passive system with reascertainments and medical
record reviews of all spina bifida cases and some muscular dystrophy cases.
bEllipses indicate that the cells contain less than 5 individuals; owing to confidentiality concerns, the exact number has been suppressed.
cSouth Carolina and Colorado differed in the rigor of the active case ascertainment. Colorado, as part of Centers for Disease Control and Prevention’s
Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), used a very thorough protocol for active case ascertainment. South
Carolina was less intensive, recording fewer key variables. Both recorded counts for the 9 major forms of muscular dystrophy. Kansas did not collect
data on Muscular Dystrophy or Fragile X.
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Table 4. Prevalence rates of spina bifida, muscular dystrophy, and fragile X syndrome in the 3 states, based on reference population.
KansasColoradoSouth CarolinaMeasure
2,904,021 state population for pas-
sive
508,803 for 1 county for active case
ascertainment
176,169 state for younger than 3
years
4,832,482 state population for pas-
sive
1,170,249 for 5 countiesa for active
case ascertainment





3.35/10,000 younger than 3 years2.16/10,000 active
12.15/10,000 passive
Rate of spina bifida
N/Ac1.29/10,0003.28/10,000 active
6.84/10,000 passive
Rate of muscular dystrophy
N/A0.01/10,0001.20/10,000 active
1.65/10,000 passive
Rate of fragile X syndrome
a The 5 South Carolina counties for active case ascertainment are as follows: Berkeley, Dorchester, Charleston, Lexington, and Richland.
b Only 1 Kansas county was included in active case ascertainment.
c N/A: not applicable.
Barriers to Implementation
The Colorado team reported no major problems implementing
this project as they already actively ascertained or reascertained
from passive reports the cases of muscular dystrophy and spina
bifida. The limited time for this project (2 years) did not allow
Colorado to officially request approval from the state legislature
to change the age of reporting for fragile X syndrome from 3
to 10 years, as has been done with autism and fetal alcohol
syndrome. Therefore, Colorado did not have any prevalent cases
of fragile X syndrome to report and only 6 incident cases.
The major barrier to implementing a combined passive and
active case ascertainment system for rare disorders in South
Carolina is cost. Passive data sources are readily available and
the active case ascertainment system is a natural extension of
the ongoing DHEC Birth Defects Monitoring Program; however,
the incremental cost of expanding active case ascertainment can
be substantial. For this project, a full-time registered nurse with
previous active case ascertainment experience was hired. The
costs for the project included her salary and fringe benefits,
training and travel, the customary clinical review of cases found,
and the storage and protection of data. Finally, the utility of
identifying and monitoring new cases needs to be justified with
clear benefits for the patients and their caregivers.
In Kansas, the BDIS relies heavily on data from birth certificates
with the age of 5 years being the limit for reporting genetic or
congenital conditions [28,29]. The monitoring of conditions
that are detectable long after birth under such constraints, such
as fragile X syndrome and muscular dystrophy, could be
challenging. After limiting the test to spina bifida, a major policy
barrier surfaced. The Kansas law that created BDIS also made
the records contained in this system strictly confidential and
disclosable only by court order. Public disclosure is only allowed
in summary or aggregated formats (law identified in Table 1);
therefore, merging, matching, and analyzing the data had to be
performed in situ by team members affiliated with the Kansas
Department of Health and Environment.
To facilitate data sharing regarding medical records, the Kansas
team contacted KFMC to perform medical record abstraction
for this project. The KFMC has an established and credible
relationship with health care providers in Kansas and recently
partnered with the Kansas Department of Health and
Environment to complete a record review project on their behalf.
However, even with this established relationship and the state
law, there was a limited response from providers to participate
in the active component.
Discussion
This passive and active case ascertainment project was carried
out to test the feasibility of establishing rare conditions passive
and active case ascertainment systems for more than one
condition at a time in states with varying levels of existing
infrastructure. Having states at various stages of readiness for
passive and active case ascertainment in this project allows for
the identification of factors that may facilitate or impede the
development of such systems.
The approach was to first assess the existing birth defects
monitoring system in all 3 states, and then to identify additional
processes that could be used to implement an ongoing rare
conditions passive and active case ascertainment system. This
project was not designed to compare active with passive case
ascertainment; rather, it was designed to assess the feasibility
of combining both types of case ascertainment systems to
increase the yield of cases. The early steps for this project were
successful: separately, all teams from the 3 states identified
local data sources and determined the data elements to be
collected. Together, the teams worked on the standardization
of variable definitions to make the results comparable across
systems and states. The definitions of the variables and their
connections to the data sources were precisely documented to
assure accurate replication.
This feasibility exercise helped us better understand the ways
that states approach passive and active case ascertainment. Some
states, like South Carolina and Colorado, have legal authority
and ample experience monitoring birth defects. These 2 states
use a variety of data sources for their passive and active case
ascertainment systems, but active case ascertainment of rare
diseases relies on obtaining funding through national programs,
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such as MD STARnet. In fact, after completion of this project,
South Carolina was able to apply and get funding to join the
national MD STARnet network. On the other hand, for other
states, such as Kansas, the birth defects monitoring may have
limited data sources and the implementation of a passive and
active case ascertainment system to monitor more than one rare
condition at once with both passive and active components
would be a major challenge. Thus, as has been seen with other
passive and active case ascertainment systems, funding through
national networks or advocacy foundations appears to be the
most viable approach to support the establishment of passive
and active case ascertainment of rare conditions [35].
Because the purpose of the project was to assess the feasibility
of establishing active and passive case ascertainment for rare
conditions, we cannot guarantee the accuracy of the prevalence
estimates; we have presented them here to provide reference
for future work. Although the rates are not directly comparable
because of state-to-state variations in data sources, prevalence
of spina bifida was 2.16/10,000 people in South Carolina (active
case ascertainment component), 3.35/10,000 in Colorado
(passive case ascertainment component supplemented with case
confirmations and clinical reviews), and 3.04/10,000 in Kansas
(passive case ascertainment component; active case
ascertainment resulted in limited follow-up). The prevalence of
muscular dystrophy differed between South Carolina
(3.28/10,000) and Colorado (1.29/10,000), although South
Carolina used less rigorous criteria than the MD STARnet
criteria and process [32] used by Colorado staff to define 9
forms of the condition. South Carolina was the only state able
to test a combined passive and active case ascertainment
approach for fragile X syndrome; the prevalence was
1.20/10,000 for active case ascertainment and 1.65/10,000 for
passive case ascertainment.
The lessons learned have been valuable for the 3 states
participating in this pilot project. Team participation and
problem-solving approaches were excellent; however, state
health departments will face obstacles if they seek to implement
a combined passive and active case ascertainment system to
simultaneously track rare disorders statewide. Although joint
passive and active case ascertainment of rare disorders is
feasible, only the passive component of case ascertainment
seems to be readily available for use, even with limitations
regarding data collection. The incorporation of the active
component appears to be more of a long-term goal.
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